Mitogenic actions of peroxisome proliferators: Involvement of protein kinase C and tumor necrosis factor α

Drug Metabolism Reviews

Volumn 29, Issue 1-2, 1997, Pages 235-260

  Bojes, Heidi K ^a   Rose, Michelle L ^a   Keller, Barbara J ^a   Germolec, Dori R ^a   Simeonova, Petia ^a   Luster, Micheal I ^a   Thurman, Ronald G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYLHEXANOL; BROXURIDINE; CYANIDE; KETONE BODY; LACTATE DEHYDROGENASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MITOGENIC AGENT; NAFENOPIN; OXYGEN; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; PROTEIN KINASE C; TOMELUKAST; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DIETARY INTAKE; KUPFFER CELL; LIVER PERFUSION; LIVER TOXICITY; MALE; MITOCHONDRIAL RESPIRATION; MITOGENICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; LIVER; METABOLISM; MICROBODY; OXYGEN CONSUMPTION; PHYSIOLOGY; REVIEW;

ANIMALS; CARCINOGENS; COENZYME A LIGASES; KUPFFER CELLS; LIVER; MICROBODIES; MITOGENS; OXYGEN CONSUMPTION; PROTEIN KINASE C; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030610416     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.3109/03602539709037584     Document Type: Conference Paper

References (71)

1. J. M. Hawkins, W. E. Jones, F. W. Bonner, and G. G. Gibson, The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney, Drug Metab. Dispos., 18, 441-515 (1987).
2. J. K. Reddy and N. D. Lalwani, Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plastciizers to humans, Crit. Rev. Toxicol., 12, 1-58 (1983).
3. P. I. Eacho, T. L. Lanier, and C. A. Brodhecker, Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of WY-14,643 to clofibric acid, nafenopin and LY171883, Carcinogenesis, 12, 1557-1561 (1991).
4. D. S. Marsman, R. C. Cattley, J. G. Conway, and J. A. Popp, Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,643) in rats, Cancer Res., 48, 6739-6744 (1988).
5. J. K. Reddy and M. S. Roa, Oxidative DNA damage caused by persistent peroxisome proliferation: Its role in hepatocarcinogenesis, Mutat. Res., 214, 63-68 (1989).
6. G. P. Mannaerts, P. Van Velhoven, A. Van Broekhoven, G. Vandebroek, and L. J. Debeer, Evidence that peroxisomal acyl-CoA synthetase is located at the cytoplasmic side of the peroxisomal membrane, Biochem. J., 20, 17-23 (1982).
7. J. G. Conway, K. E. Tomaszewski, M. J. Olsen, R. C. Cattely, D. S. Marsman, and J. A. Popp, Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,643), Carcinogenesis, 10, 513-519 (1989).
8. H. Kasai, Y. Okada, S. Nishimura, M. S. Roa, and J. K. Reddy, Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res., 49, 2603-2605 (1989).
9. A. Takagi, K. Sai, T. Umemura, R. Hasegawa, and Y. Kurokawa, Production of 8-hydroxydeoxyguanosine in rodent liver by the administration of peroxisome proliferators, in Peroxisomes: Biology and Importance in Toxicology and Medicine (G. Gordon and B. Lake, eds.), Taylor and Francis, London, 1983.
10. B. G. Lake, Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and cheimcals, Annu. Rev. Pharmacol. Toxicol., 35, 483-507 (1995).
11. P. Nicholls and G. R. Schonbaum, in Catalases (P. D. Boyer, ed.), Academic Press, New York, 1963, pp. 147-225.
12. 2 production in intact liver, Toxicol. Lett., 60, 61-68 (1992).
13. 2 production by peroxisomes, Eur. J. Biochem., 172, 477-481 (1988).
14. 2 production in intact perfused rat liver, Biochem. J., 196, 705-712 (1981).
15. D. J. Kornburst, T. R. Barfknecht, P. Ingram, and J. D. Shelburne, Effect of di(2-ethylhexyl)phthalate on DNA repair and lipid peroxidation in rat hepatocytes and on metabolic cooperation in Chinese hamster V-79 cells, J. Toxicol. Environ. Health, 13, 99-116 (1984).
16. N. C. Barrass, R. J. Price, B. G. Lake, and T. C. Orton, Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver, Carcinogenesis, 14, 1451-1456 (1993).
17. R. J. Price, J. G. Evans, and B. G. Lake, Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster, Food Chem. Toxicol., 30, 937-944 (1992).
18. R. C. Cattley, D. S. Marsman, and J. A. Popp, Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver, Carcinogenesis, 12, 469-473 (1991).
19. B. Kraupp-Grasl, W. Huber, H. Taper, and R. Schulte-Hermann, Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously, Cancer Res., 51, 666-671 (1991).
20. D. S. Marsman and J. A. Popp, Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, WY-14,643, Carcinogenesis, 15, 111-117 (1994).
21. B. J. Keller, H. Yamanaka, D. Liang, F. C. Kauffman, and R. G. Thurman, Oxygen-dependent hepatotoxicity to ethylhexanol in the perfused rat liver: Mitochondria as a site of action, J. Pharmacol. Exp. Ther., 252, 1355-1360 (1990).
22. B. J. Keller, D. S. Marsman, J. A. Popp, and R. G. Thurman, Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation, Biochim. Biophys. Acta, 1102, 237-244 (1992).
23. B. J. Keller, B. U. Bradford, D. S. Marsman, R. C. Cattley, J. A. Popp, H. K. Bojes, and R. G. Thurman, The nongenotoxic hepatocarcinogen WY-14,643 is an uncoupler of oxidative phosphorylation in vivo, Toxicol. Appl. Pharmacol., 119, 52-58 (1993).
24. S. A. Jewell, G. Bellomo, T. Hjordis, S. Orrenius, and M. T. Smith, Bleb formation in hepatocytes during drug metabolism caused by disturbance in thiol and calcium ion homeostasis, Science, 217, 1257-1259 (1982).
25. H. K. Bojes, P. J. Sausen, R. C. Cattley, B. J. Keller, and R. G. Thurman, Paradoxical increase in peroxisomal cyanide-insensitive respiration following dietary exposure to WY-14,634 in the perfused liver, Toxicol. Appl. Pharmacol., 137, 202-209 (1996).
26. R. G. Thurman and R. Scholz, Mixed function oxidation in perfused rat liver. The effect of aminopyrine on oxygen uptake, Eur. J. Biochern., 10, 459-467 (1969).
27. Y. Nishizuka, The role of protein kinase C in cell surface signal transduction and tumor promotion, Nature, 308, 693-698 (1984).
28. Y. Nishizuka, The molecular heterogeneity of protein kinase C and its implications for cellular regulation, Nature, 334, 661-665 (1988).
29. H. K. Bojes and R. G. Thurman, Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo, Toxicol. Appl. Pharmacol., 126, 233-239 (1994).
30. M. Bronfman, A. Orellana, M. N. Morales, F. Bieri, F. Waechter, W. Staubli, and P. Bentley, Potentiation of diacylglycerol-activated protein kinase C by acyl-coenzyme A thioesters of hypolipidaemic drugs, Biochem. Biophys. Res. Commun., 159, 1026-1031 (1989).
31. +2-dependent protein kinase, Science, 224, 622-624 (1984).
32. F. E. Mitchell, S. C. Price, R. C. Hinton, P. Grasso, and J. W. Bridges, Time and dose-response study of the effects on the rates of the plasticizer di(2-ethylhexyl)phthalate, Toxol. Appl. Pharmacol., 81, 371-392 (1985).
33. S. C. Price, R. H. Hinton, F. E. Mitchell, D. E. Hall, P. Grasso, G. F. Blane, and J. W. Brigdes, Time and dose study on the response on rats to the hypolipidaemic drug fenofibrate, Toxicology, 41, 169-191 (1986).
34. P. S. Foxworthy, D. N. Perry, D. M. Hoover, and P. I. Eacho, Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given peroxisome proliferator LY171883, Toxicol. Appl, Pharmacol., 106, 375-383 (1990).
35. M. E. George and M. E. Andersen, Toxic effects of nonadecafluoro-n-decanoic acid in rats, Toxicol. Appl. Pharmacol., 85, 169-180 (1986).
36. S. K. Krisans, R. M. Mortensen, and P. B. Lazarow, Acyl-CoA synthetase in rat liver peroxisomes, J. Biol. Chem., 255, 9599-9607 (1980).
37. H. K. Bojes and R. G. Thurman, Potent peroxisome proliferators inhibit β-oxidation in the isolated perfused rat liver, Toxicol. Appl. Pharmacol., in press (1996).
38. J. R. Baldwin, D. T. Witiak, and D. R. Feller, Disposition of clofibrate in rat. Acute and chronic adminstration, Biochem. Pharmacol., 29, 3143-3154 (1980).
39. R. A. Okerholm, F. J. Keeley, F. E. Peterson, and A. J. Glazko, The metabolism of gemfibrozil, Proc. Roy. Soc. Lond., 69, 11-14 (1976).
40. I. Issemann and S. Green, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645-650 (1990).
41. M. Gottlicher, E. Wildmark, L. Qiao, and J. Gustafsson, Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor, Proc. Natl. Acad. Sci. USA, 89, 4653-4657 (1992).
42. M. E. Greenberg, L. A. Greene, and E. B. Zeff, Never growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells, J. Biol. Chem., 260, 14101-14110 (1985).
43. M. E. Greenberg and E. B. Ziff, Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene, Nature, 311, 433-438 (1984).
44. L. A. Hansen, N. A. Monteiro-Riviere, and R. C. Smart, Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: Association with epidermal hyperplasia and tumor promotion, Cancer Res., 50, 5740-5745 (1990).
45. T. Sher, H. F. Yi, O. W. McBride, and F. J. Gonzalez, cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor, Biochemistry, 32, 98-5604 (1993).
46. T. C. Aldridge, J. D. Tugwood, and S. Green, Identification and chacracterization of DNA elements implicated in the regulation of CYP4A1 transcription, Biochem. J., 306, 473-479 (1995).
47. Y.-J. Y. Wan, M. Morimoto, R. G. Thurman, H. K. Bojes, and S. French, Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease, Life Sci., 56, 307-317 (1994).
48. S. S. Lee, T. Pineau, J. Drago, E. J. Lee, J, W, Owens, D. L. Kroetz, P. M. Fernandez-Salguero et al., Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome prolifeators, Mol. Cell Biol., 15, 3012-3022 (1995).
49. D. S. Marsman, C. L. Swanson-Pfeiffer, and J. A. Popp, Lack of comitogenicity by the peroxisome proliferator hepatocarcinogens, WY-14,643 and clofibric acid, Toxicol. Appl. Pharmacol., 122, 1-6 (1993).
50. H. S. Beyer and A. Theologides, Tumor necrosis factor-α is a direct hepatocyte mitogen in the rat, Bichem. Mol. Biol. Int., 29, 1-4 (1993).
51. +2 flux as an initial event in phagocytosis by rat Kupffer cells, Eur. J. Biochem., 131, 539-543 (1983).
52. A. R. Buckley, P. D. Crowe, and D. H. Russell, Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen, Proc. Natl. Acad. Sci. USA, 85, 8649-8653 (1988).
53. G. K. Michalopoulos, Liver regeneration: Molecular mechanisms of growth control, FASEB J., 4, 176-187 (1990).
54. H. K. Bojes and R. G. Thurman, Peroxisome proliferators activate Kupffer cells in vivo, Cancer Res., 56, 1-4 (1996).
55. M. L. Rose and R. G. Thurman, Rapid phagocytosis of particles of the peroxisome proliferator LY171883 activates Kupffer cells, Fundam. Appl. Toxicol., 30, 1060 (1996).
56. K. Decker, Biologically active products of stimulated liver macrophages (Kupffer cells), Eur. J. Biochem., 192, 245-261 (1990).
57. 4 from rat Kupffer cells, Prostanglandins Leuko. Essent. Fatty Acids, 36, 125-128 (1989).
58. M. N. Pieters, S. Esbach, D. Schouten, A. Brower, D. L. Knook, and T. J. von Berkel, Cholesteryl esters from oxidized low-density lipoproteins are in vivo rapidly hydrolyzed in rat Kupffer cells and transported to liver parenchymal cells and bile, Hepatology, 19, 1459-1467 (1994).
59. A. C. Bayly, R. A. Roberts, and C. Dive, Suppression of liver cell apoptosis in vitro by the nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin, J. Cell Biol., 125, 197-203 (1994).
60. L. W. Daniel, in Phopholipases (W. E. M. Lands, ed.), Biochemistry of Arachidonic Acid Metabolism, Matinus Nijhoff, Boston, 1985, pp. 175-193.
61. Y. Nakagawa, T. Matsumura, M. Goto, W. Qu, F. C. Kauffman, and R. G. Thurman, Increase in oxygen uptake due to arachidonic acid is oxygen dependent in the perfused liver, Am. J. Physiol., 266, G953-G959 (1994).
62. 2 consumption: Effect of alcohol treatment on cell-cell communication, Am. J. Physiol., 270, G575-G580 (1996).
63. B. Beutler and A. Cerami, Cahectin (tumor necrosis factor): A macrophage hormone governing cellular metabolism and inflammatory response, Endocrine Rev., 9, 57-66 (1988).
64. P. Akerman, P. Cote, S. Q. Yang, C. McClain, S. Nelson, G. J. Bagby, A. M. Diehl et al., Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy, Am. J. Physiol., 263, G579-G585 (1992).
65. H. K. Bojes, D. R. Gemolec, P. Simeonova, A. Bruccoleri, R. Schoonhoven, M. I. Luster, and R. G. Thurman, Antibodies to tumor necrosis factor α prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643, Carcinogenesis (1997) (in press).
66. R. P. Cornell, B. L. Lijequist, and K. F. Bartizal, Depresses liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice, Hepatology, 11, 916-922 (1990).
67. Y. Endo, R. Suzuki, and K. Kumagi, Induction of ornithine decarboxylase in liver and spleen of mice by interleuken 1-like factors produced from a macrophage line, Biochem. Biophys. Acta, 838, 343-350 (1985).
68. T. Shinagawa, K. Yoshioka, S. Kakumu, T. Wakita, T. Ishikawa, Y. Itoh, and M. Takayanagi, Apoptosis in cultured rat hepatocytes: The effects of tumor necrosis factor α and interferon γ, J. Pathol., 165, 247-253 (1991).
69. A. G. Stewart, P. R. Tomlinson, D. J. Fernandes, J. W. Wilson, and T. Harris, Tumor necrosis factor alpha modulates mitogenic responses of human cultured airway smooth muscle, Am. J. Respiratory Cell Mol Biol., 12, 110-119 (1995).
70. Y. A. Hannun, The spingomyelin cycle and the second messenger function of ceramide, J. Biol. Chem., 269, 3125-3128 (1994).
71. R. A. Heller and M. Kronke, Tumor necrosis facator receptor-mediated signaling pathways, J. Cell. Biol., 126, 5-9 (1994).